H33_HUMAN - dbPTM
H33_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID H33_HUMAN
UniProt AC P84243
Protein Name Histone H3.3
Gene Name H3F3A
Organism Homo sapiens (Human).
Sequence Length 136
Subcellular Localization Nucleus. Chromosome.
Protein Description Variant histone H3 which replaces conventional H3 in a wide range of nucleosomes in active genes. Constitutes the predominant form of histone H3 in non-dividing cells and is incorporated into chromatin independently of DNA synthesis. Deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling..
Protein Sequence MARTKQTARKSTGGKAPRKQLATKAARKSAPSTGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSAAIGALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Asymmetric dimethylarginine-----MARTKQTARK
-----CCCCCHHHHH
40.95-
3Citrullination-----MARTKQTARK
-----CCCCCHHHHH
40.9516567635
3Methylation-----MARTKQTARK
-----CCCCCHHHHH
40.9518077460
4Phosphorylation----MARTKQTARKS
----CCCCCHHHHHC
20.2617938195
5Allysine---MARTKQTARKST
---CCCCCHHHHHCC
39.85-
5Acetylation---MARTKQTARKST
---CCCCCHHHHHCC
39.8516457588
5Crotonylation---MARTKQTARKST
---CCCCCHHHHHCC
39.8521925322
5Deamination---MARTKQTARKST
---CCCCCHHHHHCC
39.8527735137
5Methylation---MARTKQTARKST
---CCCCCHHHHHCC
39.8516457588
5Other---MARTKQTARKST
---CCCCCHHHHHCC
39.8527105115
6Formation of an isopeptide bond--MARTKQTARKSTG
--CCCCCHHHHHCCC
39.5232273471
6Serotonylation--MARTKQTARKSTG
--CCCCCHHHHHCCC
39.5230867594
7Phosphorylation-MARTKQTARKSTGG
-CCCCCHHHHHCCCC
29.9520228790
9CitrullinationARTKQTARKSTGGKA
CCCCHHHHHCCCCCC
36.52-
9CitrullinationARTKQTARKSTGGKA
CCCCHHHHHCCCCCC
36.5215345777
9MethylationARTKQTARKSTGGKA
CCCCHHHHHCCCCCC
36.52-
10"N6,N6,N6-trimethyllysine"RTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.32-
10AcetylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3211242053
10ButyrylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3227105113
10CrotonylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3221925322
10LactoylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3231645732
10MethylationRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3211242053
10OtherRTKQTARKSTGGKAP
CCCHHHHHCCCCCCC
50.3227105115
11ADP-ribosylationTKQTARKSTGGKAPR
CCHHHHHCCCCCCCH
27.0828190768
11O-linked_GlycosylationTKQTARKSTGGKAPR
CCHHHHHCCCCCCCH
27.0828510447
11PhosphorylationTKQTARKSTGGKAPR
CCHHHHHCCCCCCCH
27.0810469656
12PhosphorylationKQTARKSTGGKAPRK
CHHHHHCCCCCCCHH
53.6526074081
15AcetylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4717194708
15GlutarylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4731542297
15LactoylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.47-
15MethylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.47-
15OtherARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4727105115
15SuccinylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4717194708
15SumoylationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4717194708
15UbiquitinationARKSTGGKAPRKQLA
HHHCCCCCCCHHHHH
57.4717194708
18Asymmetric dimethylarginineSTGGKAPRKQLATKA
CCCCCCCHHHHHHHH
44.18-
18CitrullinationSTGGKAPRKQLATKA
CCCCCCCHHHHHHHH
44.1816567635
18MethylationSTGGKAPRKQLATKA
CCCCCCCHHHHHHHH
44.1815345777
19N6-crotonyl-L-lysineTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.91-
19AcetylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9117194708
19ButyrylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9127105113
19CrotonylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9121925322
19GlutarylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9131542297
19LactoylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9131645732
19MethylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9116267050
19OtherTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9127105115
19SumoylationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9117194708
19UbiquitinationTGGKAPRKQLATKAA
CCCCCCHHHHHHHHH
48.9121890473
24N6-crotonyl-L-lysinePRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.15-
24AcetylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1517194708
24ButyrylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1527105113
24CrotonylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1521925322
24GlutarylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1531542297
24LactoylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1531645732
24MethylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1517194708
24OtherPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1527105115
24SumoylationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1517194708
24UbiquitinationPRKQLATKAARKSAP
CHHHHHHHHHHHHCC
34.1517194708
27CitrullinationQLATKAARKSAPSTG
HHHHHHHHHHCCCCC
38.02-
27CitrullinationQLATKAARKSAPSTG
HHHHHHHHHHCCCCC
38.0216567635
28"N6,N6,N6-trimethyllysine"LATKAARKSAPSTGG
HHHHHHHHHCCCCCC
46.36-
28AcetylationLATKAARKSAPSTGG
HHHHHHHHHCCCCCC
46.3617194708
28CrotonylationLATKAARKSAPSTGG
HHHHHHHHHCCCCCC
46.3621925322
28GlutarylationLATKAARKSAPSTGG
HHHHHHHHHCCCCCC
46.3631542297
28LactoylationLATKAARKSAPSTGG
HHHHHHHHHCCCCCC
46.3631645732
28MethylationLATKAARKSAPSTGG
HHHHHHHHHCCCCCC
46.3617194708
28OtherLATKAARKSAPSTGG
HHHHHHHHHCCCCCC
46.3627105115
28UbiquitinationLATKAARKSAPSTGG
HHHHHHHHHCCCCCC
46.3617194708
29ADP-ribosylationATKAARKSAPSTGGV
HHHHHHHHCCCCCCC
39.6028190768
29PhosphorylationATKAARKSAPSTGGV
HHHHHHHHCCCCCCC
39.6025159151
32PhosphorylationAARKSAPSTGGVKKP
HHHHHCCCCCCCCCC
39.1325159151
33PhosphorylationARKSAPSTGGVKKPH
HHHHCCCCCCCCCCC
36.5723403867
37"N6,N6,N6-trimethyllysine"APSTGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.95-
37AcetylationAPSTGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.9517194708
37MethylationAPSTGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.9517194708
37OtherAPSTGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.9524681537
37UbiquitinationAPSTGGVKKPHRYRP
CCCCCCCCCCCCCCC
64.9521906983
38AcetylationPSTGGVKKPHRYRPG
CCCCCCCCCCCCCCC
43.5826051181
38MethylationPSTGGVKKPHRYRPG
CCCCCCCCCCCCCCC
43.5824129315
38UbiquitinationPSTGGVKKPHRYRPG
CCCCCCCCCCCCCCC
43.58-
41MethylationGGVKKPHRYRPGTVA
CCCCCCCCCCCCCHH
37.37-
42PhosphorylationGVKKPHRYRPGTVAL
CCCCCCCCCCCCHHH
20.3728152594
43MethylationVKKPHRYRPGTVALR
CCCCCCCCCCCHHHH
24.11-
46PhosphorylationPHRYRPGTVALREIR
CCCCCCCCHHHHHHH
12.8030266825
50MethylationRPGTVALREIRRYQK
CCCCHHHHHHHHHHH
27.79-
55PhosphorylationALREIRRYQKSTELL
HHHHHHHHHHCHHHH
15.5022817900
57"N6,N6,N6-trimethyllysine"REIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.87-
57AcetylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8717194708
57CrotonylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8721925322
57GlutarylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8731542297
57LactoylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.87-
57MethylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8717194708
57OtherREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8727105115
57SuccinylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8722389435
57SumoylationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8722389435
57UbiquitinationREIRRYQKSTELLIR
HHHHHHHHCHHHHHH
50.8717194708
58PhosphorylationEIRRYQKSTELLIRK
HHHHHHHCHHHHHHH
16.1623401153
59PhosphorylationIRRYQKSTELLIRKL
HHHHHHCHHHHHHHC
37.3730266825
64MethylationKSTELLIRKLPFQRL
HCHHHHHHHCCHHHH
34.13-
65MethylationSTELLIRKLPFQRLV
CHHHHHHHCCHHHHH
54.2216267050
65OtherSTELLIRKLPFQRLV
CHHHHHHHCCHHHHH
54.2224681537
80"N6,N6,N6-trimethyllysine"REIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.79-
80AcetylationREIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.7929211711
80GlutarylationREIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.7931542297
80LactoylationREIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.7931645732
80MethylationREIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.7929211711
80OtherREIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.7927105115
80SuccinylationREIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.7929211711
80SumoylationREIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.7929211711
80UbiquitinationREIAQDFKTDLRFQS
HHHHHHHHHCHHHHH
49.7929211711
81PhosphorylationEIAQDFKTDLRFQSA
HHHHHHHHCHHHHHH
40.0123401153
84MethylationQDFKTDLRFQSAAIG
HHHHHCHHHHHHHHH
30.30-
87PhosphorylationKTDLRFQSAAIGALQ
HHCHHHHHHHHHHHH
19.5620068231
97PhosphorylationIGALQEASEAYLVGL
HHHHHHHHHHHHHHH
23.2328464451
100PhosphorylationLQEASEAYLVGLFED
HHHHHHHHHHHHHCC
9.6220068231
108PhosphorylationLVGLFEDTNLCAIHA
HHHHHCCCCEEEEEE
23.9320068231
111S-nitrosylationLFEDTNLCAIHAKRV
HHCCCCEEEEEEEEC
3.4725040305
116AcetylationNLCAIHAKRVTIMPK
CEEEEEEEECEECHH
32.9919520870
116GlutarylationNLCAIHAKRVTIMPK
CEEEEEEEECEECHH
32.9931542297
119PhosphorylationAIHAKRVTIMPKDIQ
EEEEEECEECHHHHH
18.6520068231
121SulfoxidationHAKRVTIMPKDIQLA
EEEECEECHHHHHHH
2.1728183972
123AcetylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
123GlutarylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5131542297
123MethylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
123OtherKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5127105115
123SuccinylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
123SumoylationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
123UbiquitinationKRVTIMPKDIQLARR
EECEECHHHHHHHHH
50.5119520870
129MethylationPKDIQLARRIRGERA
HHHHHHHHHHHCCCC
43.05-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
4TPhosphorylationKinaseGSG2Q8TF76
GPS
7TPhosphorylationKinasePKC-Uniprot
7TPhosphorylationKinasePKC-FAMILY-GPS
10SPhosphorylationKinaseAURKBQ96GD4
GPS
10SPhosphorylationKinasePRKACAP17612
GPS
10SPhosphorylationKinaseFYNP06241
PSP
11SPhosphorylationKinaseAURKBQ96GD4
PhosphoELM
11SPhosphorylationKinaseALTERNATE-Uniprot
11SPhosphorylationKinasePAK1Q13153
GPS
11SPhosphorylationKinaseRPS6KA5O75582
GPS
11SPhosphorylationKinaseRPS6KA4O75676
GPS
11SPhosphorylationKinaseRPS6KA3P51812
GPS
11SPhosphorylationKinaseAURKCQ9UQB9
GPS
12TPhosphorylationKinasePKC-FAMILY-GPS
12TPhosphorylationKinasePKC-Uniprot
28SPhosphorylationKinasePRKACAP17612
GPS
28SPhosphorylationKinaseAURKBQ96GD4
GPS
29SPhosphorylationKinaseRPS6KA5O75582
GPS
29SPhosphorylationKinaseAURKCQ9UQB9
GPS
29SPhosphorylationKinaseALTERNATE-Uniprot
29SPhosphorylationKinaseAURKBQ96GD4
PhosphoELM
31SPhosphorylationKinaseCHEK1O14757
GPS
45TPhosphorylationKinaseDYRK3O43781
PSP
45TPhosphorylationKinaseDYRK2Q92630
PSP
45TPhosphorylationKinaseDYRK1BQ9Y463
PSP
45TPhosphorylationKinaseDYRK1AQ63470
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
3RMethylation

18077460
4TPhosphorylation

16267050
5Kubiquitylation

16267050
5KAcetylation

16267050
5KMethylation

18077460
5KMethylation

30867594
5KMethylation

16267050
5KMethylation

16267050
5KPhosphorylation

16267050
5KMethylation

16267050
5KMethylation

16267050
7TPhosphorylation

16267050
7TMethylation

16267050
9RMethylation

18077460
9RMethylation

16567635
9RMethylation

16267050
9RCitrullination

16567635
9RAcetylation

16267050
10KPhosphorylation

30257210
10KPhosphorylation

16267050
10KPhosphorylation

16267050
10KMethylation

16267050
10KMethylation

16267050
10KPhosphorylation

16267050
10KAcetylation

16267050
10KAcetylation

16267050
10KAcetylation

16267050
10KAcetylation

30257210
10KMethylation

16267050
10KMethylation

16267050
10KMethylation

16267050
10KMethylation

16267050
11SAcetylation

16267050
11SAcetylation

16267050
11SAcetylation

30257210
11SMethylation

16267050
11SMethylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

16267050
11SPhosphorylation

30257210
12TPhosphorylation

16267050
12TMethylation

16267050
12TPhosphorylation

16267050
18RCitrullination

16567635
18RAcetylation

16267050
18RMethylation

16267050
18RMethylation

18077460
18RMethylation

16567635
19KMethylation

16267050
19KAcetylation

16267050
24KMethylation

16267050
24KAcetylation

16267050
28KMethylation

16267050
28KMethylation

16267050
29SPhosphorylation

16267050
32SPhosphorylation

16267050
37KMethylation

16267050
57KMethylation

16267050
80KSuccinylation

29211711
80Kubiquitylation

16267050
80KMethylation

16267050
80KMethylation

16267050
80KMethylation

16267050
120KMethylation

16267050
120Kubiquitylation

16267050
123KAcetylation

16267050
123KSuccinylation

27436229

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of H33_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HIRA_HUMANHIRAphysical
20211137
HIRA_HUMANHIRAphysical
14718166
NASP_HUMANNASPphysical
14718166
IPO4_HUMANIPO4physical
14718166
RBBP4_HUMANRBBP4physical
14718166
HAT1_HUMANHAT1physical
14718166
ASF1A_HUMANASF1Aphysical
14718166
ASF1B_HUMANASF1Bphysical
14718166
ASH1L_HUMANASH1Lphysical
17403666
CARM1_HUMANCARM1physical
17403666
EHMT1_HUMANEHMT1physical
17403666
EHMT2_HUMANEHMT2physical
17403666
KMT2C_HUMANKMT2Cphysical
17403666
KDM4C_HUMANKDM4Cphysical
17403666
HDAC5_HUMANHDAC5physical
17403666
HDAC9_HUMANHDAC9physical
17403666
NUCL_HUMANNCLphysical
17403666
SSRP1_HUMANSSRP1physical
17403666
SP16H_HUMANSUPT16Hphysical
17403666
CHD4_HUMANCHD4physical
17403666
SF3B1_HUMANSF3B1physical
17403666
TR150_HUMANTHRAP3physical
17403666
SP130_HUMANSAP130physical
17403666
TIF1B_HUMANTRIM28physical
17403666
PARP1_HUMANPARP1physical
17403666
SF3B2_HUMANSF3B2physical
17403666
HNRPK_HUMANHNRNPKphysical
17403666
CCD71_HUMANCCDC71physical
17403666
RNF41_HUMANRNF41physical
17403666
FBRL_HUMANFBLphysical
17403666
DHR12_HUMANDHRS12physical
17403666
H2B2E_HUMANHIST2H2BEphysical
17403666
CBX3_HUMANCBX3physical
17403666
H15_HUMANHIST1H1Bphysical
17403666
HMGB1_HUMANHMGB1physical
17403666
CBX5_HUMANCBX5physical
17403666
CBX1_HUMANCBX1physical
17403666
DAXX_HUMANDAXXphysical
20651253
ATRX_HUMANATRXphysical
20651253
ASF1B_HUMANASF1Bphysical
20651253
KAT2B_HUMANKAT2Bphysical
20651253
PARP1_HUMANPARP1physical
20525793
PRKDC_HUMANPRKDCphysical
20504901
TOP2A_HUMANTOP2Aphysical
20504901
ATRX_HUMANATRXphysical
20504901
DAXX_HUMANDAXXphysical
20504901
IMA3_HUMANKPNA4physical
20504901
PARP1_HUMANPARP1physical
20504901
PARP2_HUMANPARP2physical
20504901
XRCC5_HUMANXRCC5physical
20504901
XRCC6_HUMANXRCC6physical
20504901
TOP1_HUMANTOP1physical
20504901
NASP_HUMANNASPphysical
20504901
HAT1_HUMANHAT1physical
20504901
ASF1A_HUMANASF1Aphysical
20504901
ASF1B_HUMANASF1Bphysical
20504901
CABIN_HUMANCABIN1physical
22195966
UBN1_HUMANUBN1physical
22195966
HIRA_HUMANHIRAphysical
22195966
CBX3_HUMANCBX3physical
22684280
DAXX_HUMANDAXXphysical
23142979
DAXX_HUMANDAXXphysical
23075851
ASF1A_HUMANASF1Aphysical
23075851
ASF1B_HUMANASF1Bphysical
23075851
CAF1A_HUMANCHAF1Aphysical
23075851
HIRA_HUMANHIRAphysical
24209620
DAXX_HUMANDAXXphysical
24209620
H2AY_HUMANH2AFYphysical
23319141
ZMY11_HUMANZMYND11physical
24590075
ATRX_HUMANATRXphysical
24530302
DAXX_HUMANDAXXphysical
24530302
ATRX_HUMANATRXphysical
25538301
AF9_HUMANMLLT3physical
25417107
AF9_YEASTYAF9physical
25417107
AF9_SCHPOyaf9physical
25417107
AF9_MOUSEMllt3physical
25417107
ACTB_RABITACTBphysical
23689370
ASF1A_HUMANASF1Aphysical
18971269

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of H33_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-28 AND LYS-80, AND MASSSPECTROMETRY.
"Identification of histone H3 lysine 36 acetylation as a highlyconserved histone modification.";
Morris S.A., Rao B., Garcia B.A., Hake S.B., Diaz R.L.,Shabanowitz J., Hunt D.F., Allis C.D., Lieb J.D., Strahl B.D.;
J. Biol. Chem. 282:7632-7640(2007).
Cited for: ACETYLATION AT LYS-37.
"Organismal differences in post-translational modifications inhistones H3 and H4.";
Garcia B.A., Hake S.B., Diaz R.L., Kauer M., Morris S.A., Recht J.,Shabanowitz J., Mishra N., Strahl B.D., Allis C.D., Hunt D.F.;
J. Biol. Chem. 282:7641-7655(2007).
Cited for: ACETYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28; LYS-37;LYS-57 AND LYS-80, METHYLATION AT LYS-5; LYS-10; LYS-19; LYS-24;LYS-28; LYS-37; LYS-57; LYS-65; LYS-80 AND LYS-123, AND MASSSPECTROMETRY.
"Coactivator-associated arginine methyltransferase-1 enhances nuclearfactor-kappaB-mediated gene transcription through methylation ofhistone H3 at arginine 17.";
Miao F., Li S., Chavez V., Lanting L., Natarajan R.;
Mol. Endocrinol. 20:1562-1573(2006).
Cited for: ACETYLATION AT LYS-10 AND LYS-15, METHYLATION AT ARG-18, ANDCITRULLINATION AT ARG-18.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-10; LYS-15; LYS-19; LYS-24;LYS-28 AND LYS-37, AND MASS SPECTROMETRY.
"Mass spectrometric characterization of human histone H3: a bird's eyeview.";
Thomas C.E., Kelleher N.L., Mizzen C.A.;
J. Proteome Res. 5:240-247(2006).
Cited for: METHYLATION AT LYS-5 AND LYS-10, ACETYLATION AT LYS-10, AND MASSSPECTROMETRY.
"Expression patterns and post-translational modifications associatedwith mammalian histone H3 variants.";
Hake S.B., Garcia B.A., Duncan E.M., Kauer M., Dellaire G.,Shabanowitz J., Bazett-Jones D.P., Allis C.D., Hunt D.F.;
J. Biol. Chem. 281:559-568(2006).
Cited for: ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28, METHYLATIONAT LYS-5; LYS-10; LYS-19; LYS-28; LYS-37; LYS-65; LYS-80 AND LYS-123,AND MASS SPECTROMETRY.
"Modifications of human histone H3 variants during mitosis.";
Garcia B.A., Barber C.M., Hake S.B., Ptak C., Turner F.B., Busby S.A.,Shabanowitz J., Moran R.G., Allis C.D., Hunt D.F.;
Biochemistry 44:13202-13213(2005).
Cited for: PROTEIN SEQUENCE OF 28-41, METHYLATION AT LYS-5; LYS-10; LYS-28 ANDLYS-37, PHOSPHORYLATION AT THR-4; SER-11; SER-29 AND SER-32,ACETYLATION AT LYS-10 AND LYS-15, AND MASS SPECTROMETRY.
"Human spleen histone H3. Isolation and amino acid sequence.";
Ohe Y., Iwai K.;
J. Biochem. 90:1205-1211(1981).
Cited for: PARTIAL PROTEIN SEQUENCE, METHYLATION AT LYS-10; LYS-28 AND LYS-37,AND ACETYLATION AT LYS-15 AND LYS-24.
Methylation
ReferencePubMed
"Arginine methylation of the histone H3 tail impedes effectorbinding.";
Iberg A.N., Espejo A., Cheng D., Kim D., Michaud-Levesque J.,Richard S., Bedford M.T.;
J. Biol. Chem. 283:3006-3010(2008).
Cited for: METHYLATION AT ARG-3 BY PRMT6.
"Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex aremutually exclusive.";
Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M.,Schuchlautz H., Luescher B., Amati B.;
Nature 449:933-937(2007).
Cited for: METHYLATION AT ARG-3 BY PRMT6.
"PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4trimethylation.";
Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y.,Hsieh J., Bauer U.M.;
Genes Dev. 21:3369-3380(2007).
Cited for: METHYLATION AT ARG-3 BY PRMT6.
"Coactivator-associated arginine methyltransferase-1 enhances nuclearfactor-kappaB-mediated gene transcription through methylation ofhistone H3 at arginine 17.";
Miao F., Li S., Chavez V., Lanting L., Natarajan R.;
Mol. Endocrinol. 20:1562-1573(2006).
Cited for: ACETYLATION AT LYS-10 AND LYS-15, METHYLATION AT ARG-18, ANDCITRULLINATION AT ARG-18.
"Human PAD4 regulates histone arginine methylation levels viademethylimination.";
Wang Y., Wysocka J., Sayegh J., Lee Y.-H., Perlin J.R., Leonelli L.,Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G.,Clarke S., Stallcup M.R., Allis C.D., Coonrod S.A.;
Science 306:279-283(2004).
Cited for: CITRULLINATION AT ARG-9 AND ARG-18, AND METHYLATION AT ARG-18.
"Ligand-dependent activation of the farnesoid X-receptor directsarginine methylation of histone H3 by CARM1.";
Ananthanarayanan M., Li S., Balasubramaniyan N., Suchy F.J.,Walsh M.J.;
J. Biol. Chem. 279:54348-54357(2004).
Cited for: METHYLATION AT ARG-18.
"Histone H3 lysine 56 methylation regulates DNA replication throughits interaction wwith PCNA.";
Yu Y., Song C., Zhang Q., Dimaggio P.A., Garcia B.A., York A.,Carey M.F., Grunstein M.;
Mol. Cell 46:7-17(2012).
Cited for: METHYLATION AT LYS-57.
"Organismal differences in post-translational modifications inhistones H3 and H4.";
Garcia B.A., Hake S.B., Diaz R.L., Kauer M., Morris S.A., Recht J.,Shabanowitz J., Mishra N., Strahl B.D., Allis C.D., Hunt D.F.;
J. Biol. Chem. 282:7641-7655(2007).
Cited for: ACETYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24; LYS-28; LYS-37;LYS-57 AND LYS-80, METHYLATION AT LYS-5; LYS-10; LYS-19; LYS-24;LYS-28; LYS-37; LYS-57; LYS-65; LYS-80 AND LYS-123, AND MASSSPECTROMETRY.
"Mass spectrometric characterization of human histone H3: a bird's eyeview.";
Thomas C.E., Kelleher N.L., Mizzen C.A.;
J. Proteome Res. 5:240-247(2006).
Cited for: METHYLATION AT LYS-5 AND LYS-10, ACETYLATION AT LYS-10, AND MASSSPECTROMETRY.
"Expression patterns and post-translational modifications associatedwith mammalian histone H3 variants.";
Hake S.B., Garcia B.A., Duncan E.M., Kauer M., Dellaire G.,Shabanowitz J., Bazett-Jones D.P., Allis C.D., Hunt D.F.;
J. Biol. Chem. 281:559-568(2006).
Cited for: ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28, METHYLATIONAT LYS-5; LYS-10; LYS-19; LYS-28; LYS-37; LYS-65; LYS-80 AND LYS-123,AND MASS SPECTROMETRY.
"Methylation of histone H3 lysine 9 creates a binding site for HP1proteins.";
Lachner M., O'Carroll D., Rea S., Mechtler K., Jenuwein T.;
Nature 410:116-120(2001).
Cited for: METHYLATION AT LYS-10.
"Modifications of human histone H3 variants during mitosis.";
Garcia B.A., Barber C.M., Hake S.B., Ptak C., Turner F.B., Busby S.A.,Shabanowitz J., Moran R.G., Allis C.D., Hunt D.F.;
Biochemistry 44:13202-13213(2005).
Cited for: PROTEIN SEQUENCE OF 28-41, METHYLATION AT LYS-5; LYS-10; LYS-28 ANDLYS-37, PHOSPHORYLATION AT THR-4; SER-11; SER-29 AND SER-32,ACETYLATION AT LYS-10 AND LYS-15, AND MASS SPECTROMETRY.
"Human spleen histone H3. Isolation and amino acid sequence.";
Ohe Y., Iwai K.;
J. Biochem. 90:1205-1211(1981).
Cited for: PARTIAL PROTEIN SEQUENCE, METHYLATION AT LYS-10; LYS-28 AND LYS-37,AND ACETYLATION AT LYS-15 AND LYS-24.
"Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strandbreaks.";
Huyen Y., Zgheib O., Ditullio R.A. Jr., Gorgoulis V.G., Zacharatos P.,Petty T.J., Sheston E.A., Mellert H.S., Stavridi E.S.,Halazonetis T.D.;
Nature 432:406-411(2004).
Cited for: METHYLATION AT LYS-80.
Phosphorylation
ReferencePubMed
"Quantitative interaction proteomics and genome-wide profiling ofepigenetic histone marks and their readers.";
Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S.,Butter F., Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G.,Mann M.;
Cell 142:967-980(2010).
Cited for: PHOSPHORYLATION AT SER-58 AND THR-81.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29, AND MASSSPECTROMETRY.
"Serine 31 phosphorylation of histone variant H3.3 is specific toregions bordering centromeres in metaphase chromosomes.";
Hake S.B., Garcia B.A., Kauer M., Baker S.P., Shabanowitz J.,Hunt D.F., Allis C.D.;
Proc. Natl. Acad. Sci. U.S.A. 102:6344-6349(2005).
Cited for: PHOSPHORYLATION AT SER-11; SER-29 AND SER-32, AND MASS SPECTROMETRY.
"Phosphorylation of Ser28 in histone H3 mediated by mixed lineagekinase-like mitogen-activated protein triple kinase alpha.";
Choi H.S., Choi B.Y., Cho Y.-Y., Zhu F., Bode A.M., Dong Z.;
J. Biol. Chem. 280:13545-13553(2005).
Cited for: PHOSPHORYLATION AT SER-29.
"The kinase haspin is required for mitotic histone H3 Thr 3phosphorylation and normal metaphase chromosome alignment.";
Dai J., Sultan S., Taylor S.S., Higgins J.M.G.;
Genes Dev. 19:472-488(2005).
Cited for: PHOSPHORYLATION AT THR-4; SER-11 AND SER-29.
"Novel mitosis-specific phosphorylation of histone H3 at Thr11mediated by Dlk/ZIP kinase.";
Preuss U., Landsberg G., Scheidtmann K.H.;
Nucleic Acids Res. 31:878-885(2003).
Cited for: PHOSPHORYLATION AT SER-11 AND THR-12.
"Aurora-B phosphorylates Histone H3 at serine28 with regard to themitotic chromosome condensation.";
Goto H., Yasui Y., Nigg E.A., Inagaki M.;
Genes Cells 7:11-17(2002).
Cited for: PHOSPHORYLATION AT SER-11 AND SER-29.
"Identification of a novel phosphorylation site on histone H3 coupledwith mitotic chromosome condensation.";
Goto H., Tomono Y., Ajiro K., Kosako H., Fujita M., Sakurai M.,Okawa K., Iwamatsu A., Okigaki T., Takahashi T., Inagaki M.;
J. Biol. Chem. 274:25543-25549(1999).
Cited for: PROTEIN SEQUENCE OF 58-64; 117-120 AND 124-135, AND PHOSPHORYLATION ATSER-11 AND SER-29.
"Modifications of human histone H3 variants during mitosis.";
Garcia B.A., Barber C.M., Hake S.B., Ptak C., Turner F.B., Busby S.A.,Shabanowitz J., Moran R.G., Allis C.D., Hunt D.F.;
Biochemistry 44:13202-13213(2005).
Cited for: PROTEIN SEQUENCE OF 28-41, METHYLATION AT LYS-5; LYS-10; LYS-28 ANDLYS-37, PHOSPHORYLATION AT THR-4; SER-11; SER-29 AND SER-32,ACETYLATION AT LYS-10 AND LYS-15, AND MASS SPECTROMETRY.
"Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylationat histone H3K4.";
Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N.,Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N.,Beisenherz-Huss C., Gunther T., Buettner R., Schule R.;
Nature 464:792-796(2010).
Cited for: PHOSPHORYLATION AT THR-7.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-108, AND MASSSPECTROMETRY.
"Phosphorylation of histone H3 at threonine 11 establishes a novelchromatin mark for transcriptional regulation.";
Metzger E., Yin N., Wissmann M., Kunowska N., Fischer K.,Friedrichs N., Patnaik D., Higgins J.M., Potier N., Scheidtmann K.H.,Buettner R., Schule R.;
Nat. Cell Biol. 10:53-60(2008).
Cited for: PHOSPHORYLATION AT THR-12.
"JAK2 phosphorylates histone H3Y41 and excludes HP1alpha fromchromatin.";
Dawson M.A., Bannister A.J., Gottgens B., Foster S.D., Bartke T.,Green A.R., Kouzarides T.;
Nature 461:819-822(2009).
Cited for: PHOSPHORYLATION AT TYR-42.

TOP